These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16922651)

  • 1. Pharmacokinetic dosage guidelines for elderly subjects.
    Turnheim K
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):33-48. PubMed ID: 16922651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug dosage in the elderly. Is it rational?
    Turnheim K
    Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
    Turnheim K
    Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
    Mörike K; Schwab M; Klotz U
    Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose adjustment in patients with liver disease.
    Delcò F; Tchambaz L; Schlienger R; Drewe J; Krähenbühl S
    Drug Saf; 2005; 28(6):529-45. PubMed ID: 15924505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic changes in the elderly.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Mar; 9(3):161-6. PubMed ID: 3298892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy in the elderly.
    Turnheim K
    Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative drug therapy in elderly patients.
    Rivera R; Antognini JF
    Anesthesiology; 2009 May; 110(5):1176-81. PubMed ID: 19352149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in pharmacokinetics.
    Shi S; Klotz U
    Curr Drug Metab; 2011 Sep; 12(7):601-10. PubMed ID: 21495970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
    Battino D; Croci D; Mamoli D; Messina S; Perucca E
    Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs and the liver. Part III: Ageing of the liver and the metabolism of drugs.
    Woodhouse K
    Biopharm Drug Dispos; 1992 Jul; 13(5):311-20. PubMed ID: 1498264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly.
    Turnheim K
    Exp Gerontol; 2003 Aug; 38(8):843-53. PubMed ID: 12915206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicines.
    McLachlan AJ; Pont LG
    J Gerontol A Biol Sci Med Sci; 2012 Feb; 67(2):175-80. PubMed ID: 21835808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADME-tox issues for the elderly.
    Hilmer SN
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1321-31. PubMed ID: 18798701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement.
    Candore G; Caruso C; Jirillo E; Magrone T; Vasto S
    Curr Pharm Des; 2010; 16(6):584-96. PubMed ID: 20388068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on pharmacokinetics and pharmacodynamics and the aging kidney.
    Aymanns C; Keller F; Maus S; Hartmann B; Czock D
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):314-27. PubMed ID: 20056753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.
    Fagiolino P; Eiraldi R; Vázquez M
    Clin Pharmacokinet; 2006; 45(5):433-48. PubMed ID: 16640451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.